Lucid Diagnostics Inc (LUCD)

Ticker: LUCD Exchange: NMS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Past 90 days

Past 90 days

Past 90 days

Past 90 days

Company data

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2023-09-27	2023-09-26	PS Planned sale	Lapidus Stanley Non-Executive Director	9,747 -8.8% 1.45 USD 14,133	9,747 -8.8%	1.45	USD 14,133
2023-09-27	2023-09-26	PS Planned sale	Lapidus Stanley Non-Executive Director	10,000 -8.2% 1.43 USD 14,300	10,000 -8.2%	1.43	USD 14,300
2023-09-27	2023-09-26	PS Planned sale	Lapidus Stanley Non-Executive Director	10,000 -7.6% 1.47 USD 14,740	10,000 -7.6%	1.47	USD 14,740
2023-09-27	2023-09-25	PS Planned sale	Lapidus Stanley Non-Executive Director	200 -0.2% 1.43 USD 286	200 -0.2%	1.43	USD 286
2023-09-22	2023-09-21	S Sale	Lapidus Stanley Non-Executive Director	100 -0.1% 1.44 USD 144	100 -0.1%	1.44	USD 144
2023-09-22	2023-09-20	S Sale	Lapidus Stanley Non-Executive Director	412 -0.3% 1.44 USD 593	412 -0.3%	1.44	USD 593
2023-09-22	2023-09-20	S Sale	Lapidus Stanley Non-Executive Director	3,405 -2.5% 1.45 USD 4,937	3,405 -2.5%	1.45	USD 4,937
2022-09-22	2022-09-20	S Sale	Lapidus Stanley Non-Executive Director	16,864 -11.1% 1.70 USD 28,669	16,864 -11.1%	1.70	USD 28,669
2022-09-22	2022-09-20	S Sale	Lapidus Stanley Non-Executive Director	17,000 -10.0% 1.71 USD 29,014	17,000 -10.0%	1.71	USD 29,014
2021-10-20	2021-10-18	B Purchase	PAVmed Inc. Large shareholder	571,428 +2.1% 14.00 USD 7,999,992	571,428 +2.1%	14.00	USD 7,999,992